Shanghai Antengene Corporation Limited
3 clinical trials · Sponsor
◉ Watch Shanghai Antengene Corporation Limited
| Record | Firm | Date |
|---|---|---|
| A Study to Assess the Safety, Pharmacokinetics, and Preliminary Efficacy of ATG 016 Monotherapy in Patients With Advanced Solid Tumors (NCT05010525) | Shanghai Antengene Corporation Limited | 2021-09-01 |
| A Study to Evaluating the Pharmacokinetics, Safety, and Efficacy of ATG 016 Monotherapy in IPSS-R Intermediate Risk and Above Myelodysplastic Syndrome (MDS) (NCT04691141) | Shanghai Antengene Corporation Limited | 2021-02-23 |
Track Shanghai Antengene Corporation Limited automatically
Every clearance here is in the API, with alerts when new ones post.